Adalimumab/certolizumab pegolSystemic lupus erythematosus: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1876卷 / 1期

关键词：

D O I：

10.1007/s40278-021-03268-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：19 / 19

相关论文

共 50 条

[11] A case of adalimumab-induced lupus erythematosus
Al-Niaimi, F.
Tillman, D. M.
BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 : 61 - 61
[12] Adalimumab/certolizumab-pegolErectile dysfunction: case report
Reactions Weekly, 2023, 1962 (1) : 17 - 17
[13] Adalimumab/certolizumab pegol/infliximabDisseminated tuberculosis: case report
Reactions Weekly, 2017, 1682 (1) : 20 - 20
[14] Adalimumab/certolizumab-pegol/infliximabPsoriasis : case report
Reactions Weekly, 2016, 1595 (1) : 15 - 15
[15] Adalimumab-induced systemic lupus erythematosus: A case report and review of the literature
Landells, Fiona M.
Vender, Ronald
SAGE OPEN MEDICAL CASE REPORTS, 2023, 11
[16] Adalimumab/Certolizumab-pegolRelapsing Polychondritis: case report
Reactions Weekly, 2022, 1908 (1) : 21 - 21
[17] Adalimumab/certolizumab-pegolVarious toxicities: case report
Reactions Weekly, 2020, 1814 (1) : 16 - 16
[18] Certolizumab pegolDrug induced lupus: case report
Reactions Weekly, 2018, 1708 (1) : 97 - 97
[19] Adalimumab/infliximabSystemic lupus erythematosus: 2 case reports
Reactions Weekly, 2021, 1870 (1) : 20 - 20
[20] Adalimumab/certolizumab-pegolLupus-like panniculitis: case report
Reactions Weekly, 2017, 1657 (1) : 15 - 15

← 1 2 3 4 5 →